Company page

Sinomab Bioscience Ltd.

Sinomab Bioscience Ltd. is a public company listed on the Hong Kong Stock Exchange under the ticker 3681. The company has a market capitalization of approximately HKD 236.97 million. Sinomab focuses on the development of innovative therapies in the biopharmaceutical sector.

profile3681AI content: aiUpdated May 25, 2026/company/sinomab-bioscience-ltd
Sinomab Bioscience Ltd. logo
Ticker
3681
Market cap
$237.0M
Sector
Health Technology
Industry
Biotechnology